We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NGVT market cap is 1.2B. The company's latest EPS is USD -11.8373 and P/E is -2.78.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 371.7M | 340.1M | 390.6M | 376.9M | 298.8M |
| Operating Income | -111.7M | -17.4M | -287.5M | -2.3M | 31.5M |
| Net Income | -116.8M | -56M | -283.7M | -107.2M | 16.6M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.22B | 1.39B | 1.67B | 1.69B | 1.41B |
| Operating Income | 273.2M | 290.4M | 316.3M | 82.6M | -275.7M |
| Net Income | 181.4M | 118.1M | 205.7M | -5.4M | -430.3M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.62B | 2.57B | 2.28B | 2.21B | 2.02B |
| Total Liabilities | 1.99B | 2B | 1.99B | 2B | 1.83B |
| Total Equity | 631.4M | 568.2M | 284.8M | 214.5M | 195.2M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.33B | 2.47B | 2.74B | 2.62B | 2.02B |
| Total Liabilities | 1.69B | 1.8B | 2.04B | 1.99B | 1.83B |
| Total Equity | 642.1M | 673.8M | 698.3M | 631.4M | 195.2M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 205.1M | -12.1M | 17.6M | 64.1M | 128.6M |
| Investing | -77.3M | -16.3M | -34.1M | -51.5M | -79.5M |
| Financing | -99.9M | 23.4M | 33.7M | 27.4M | -70.2M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 352.4M | 293M | 313.1M | 205.1M | 128.6M |
| Investing | -110.6M | -140.6M | -553.9M | -77.3M | -79.5M |
| Financing | -50.2M | -133.1M | 48.1M | -99.9M | -70.2M |
| Market Cap | 1.2B |
| Price to Earnings Ratio | -2.78 |
| Price to Sales Ratio | 0.85 |
| Price to Cash Ratio | 17.57 |
| Price to Book Ratio | 6.12 |
| Dividend Yield | - |
| Shares Outstanding | 36.35M |
| Average Volume (1 week) | 224.58k |
| Average Volume (1 Month) | 287.56k |
| 52 Week Change | -31.16% |
| 52 Week High | 56.295 |
| 52 Week Low | 28.49 |
| Spread (Intraday) | 21.32 (40.94%) |
| Company Name | Ingevity Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.ingevity.com |
| Industry | chemicals & allied products (2800) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
